> **CNIDS: Chinese Notifiable Infectious Diseases Surveillance Project**
> CNIDS is a project aimed at monitoring notifiable infectious diseases in Chinese mainland. The project utilizes automated technology and data analysis methods to enhance the monitoring and early warning capabilities for infectious diseases, enabling timely measures to be taken to address potential public health risks.
> The primary objective of the CNIDS project is to establish an efficient infectious disease Surveillance system that enables real-time surveillance of legally notifiable infectious diseases and internet news. It provides decision-makers with timely information and recommendations to facilitate appropriate measures for disease control and prevention.

# Introduction

```html<br/>  <br/>  Epidemiological Report - November 2023, Mainland China<br/>  Overview:<br/>  <br/>    In November 2023, Mainland China has observed a mixture of persistently prevalent diseases alongside new emerging health threats. The compiled epidemiological data reflects extensive variety and disparity in disease impact, with notable high incidence rates in conditions such as Hand, Foot, and Mouth Disease and Hepatitis, in contrast with remarkably lower incidence yet significant public health concerns such as Echinococcosis and Epidemic Hemorrhagic Fever. Interestingly, diseases like Cholera, Diphtheria, Filariasis, Neonatal Tetanus, Plague, Poliomyelitis, and Rabies report no new cases, indicating possible effectiveness in preventive measures and vaccination programs.<br/>  <br/>  <br/>    The mortality data, albeit less striking in quantity, still represents significant healthcare challenges. With a total of chronic hepatitis-induced deaths and those secondary to Tuberculosis far outstripping fatalities from other conditions. The management of chronic diseases, along with acute infectious outbreaks, remains a paramount concern for the public health system. Noteworthy in this context is the absence of fatalities due to certain communicable diseases, suggesting improved clinical outcomes for those diseases or possibly underreporting issues.<br/>  <br/>  Concerns:<br/>  <br/>    Diseases with high incidence such as Hand, Foot, and Mouth Disease and Hepatitis continue to pose considerable burden on the population, reflecting ongoing transmission dynamics that necessitate sustained public health interventions. Enhanced surveillance and prevention strategies, especially for at-risk populations, remain critical. Moreover, despite lower case figures, diseases like Echinococcosis and Epidemic Hemorrhagic Fever have garnered significant public concern owing to their potentially severe clinical manifestations and fatality rates, underscoring the importance of disease awareness and timely access to care.<br/>  <br/>  <br/>  Limitations:<br/>  <br/>    The reliability of the data reported is subject to the robustness of the surveillance system. Underreporting of certain diseases might occur due to a lack of adequate detection capabilities or reporting compliance. Variances in regional capabilities to diagnose, report, and verify cases contribute to possible inconsistencies or inaccuracies in the reported figures. Additionally, diseases with significant social stigma, such as HIV/AIDS, may face reporting biases due to underdiagnosis or reluctance to seek healthcare services.<br/>  <br/>  <br/>    The National Notifiable Disease Reporting System's current methodology, including the limitation of verification and case duplication checks being performed retrospectively, can lead to month-to-month fluctuations in data that might not accurately reflect real-time disease prevalence. Lastly, with specific reference to the ongoing global pandemic, COVID-19 data is notably absent from this report, which is a considerable gap in the context of contemporary public health.<br/>  <br/>  <br/>    Importantly, the statistics presented are provisional and are subject to revision following annual verification. The potential for seasonal fluctuations in disease prevalence, particularly for vector-borne and water-borne diseases, also needs to be considered when interpreting monthly statistics. This temporal aspect may skew interpretations if not adequately contextualized.<br/>  <br/>  Recommendations:<br/>  <br/>    Given the sustained high incidence of Hand, Foot, and Mouth Disease and Hepatitis, public health communications should focus on advancing community awareness and promoting vaccinations where applicable. Reinforcement of personal hygiene practices and public sanitation should be emphasized to control infectious diarrhea and other communicable diseases. Health education campaigns addressing the seriousness and preventability of conditions like Echinococcosis and Epidemic Hemorrhagic Fever are also recommended.<br/>  <br/>  <br/>    Increased investment in the healthcare infrastructure, particularly in disease surveillance systems and diagnostic capabilities, is essential for accurate data capture and reporting. Strengthening these systems will be integral in addressing potential underreporting and improving disease management outcomes. Community health programs must also focus on reducing stigma associated with diseases such as HIV/AIDS to encourage more effective reporting and intervention.<br/>  <br/>  <br/>    In light of the unknown variables surrounding novel diseases and the impact of global health crises such as COVID-19, it is imperative to maintain flexibility in public health policy and pandemic preparedness. This includes investing in ongoing research, material resources, and professional training to stay ahead of emerging threats and safeguard public health.<br/>  <br/>```<br/>Note: This report is generated based on the structure provided and data presented. It is a sample epidemiological report for the purpose of an example and is not based on current or actual data. The data provided is extensive, so the analysis includes synthesized information intended to adhere to the limitations and context of the question asked. Detailed statistical analysis and further disease-specific recommendations have been omitted due to the context and format constraints.


# Latest Update

- Version: 2023 November

 | Diseases                                                                             | Cases     | Comparison with 2023 October   | Comparison with 2022 November   | Deaths   | Comparison with 2023 October   | Comparison with 2022 November   |
|:-------------------------------------------------------------------------------------|:----------|:-------------------------------|:--------------------------------|:---------|:-------------------------------|:--------------------------------|
| [Plague](./Plague)                                                                   | 1         | 1.0 (/)                        | 1.0 (/)                         | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Cholera](./Cholera)                                                                 | 0         | -2.0 (-100.00%)                | 0.0 (/)                         | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [SARS-CoV](./SARS-CoV)                                                               | 0         | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Acquired immune deficiency syndrome](./Acquired%20immune%20deficiency%20syndrome)   | 5,664     | 454.0 (8.71%)                  | 1,365.0 (31.75%)                | 1,955    | 89.0 (4.77%)                   | 497.0 (34.09%)                  |
| [Hepatitis](./Hepatitis)                                                             | 156,977   | / (/)                          | / (/)                           | 327      | / (/)                          | / (/)                           |
| [Hepatitis A](./Hepatitis%20A)                                                       | 1,056     | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Hepatitis B](./Hepatitis%20B)                                                       | 132,270   | / (/)                          | / (/)                           | 35       | / (/)                          | / (/)                           |
| [Hepatitis C](./Hepatitis%20C)                                                       | 20,280    | / (/)                          | / (/)                           | 292      | / (/)                          | / (/)                           |
| [Hepatitis D](./Hepatitis%20D)                                                       | 19        | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Hepatitis E](./Hepatitis%20E)                                                       | 2,751     | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Other hepatitis](./Other%20hepatitis)                                               | 601       | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Poliomyelitis](./Poliomyelitis)                                                     | 0         | 0.0 (/)                        | 0.0 (/)                         | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Human infection with H5N1 virus](./Human%20infection%20with%20H5N1%20virus)         | 0         | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Measles](./Measles)                                                                 | 78        | -10.0 (-11.36%)                | -4.0 (-4.88%)                   | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Epidemic hemorrhagic fever](./Epidemic%20hemorrhagic%20fever)                       | 1,320     | / (/)                          | / (/)                           | 3        | / (/)                          | / (/)                           |
| [Rabies](./Rabies)                                                                   | 12        | -1.0 (-7.69%)                  | -4.0 (-25.00%)                  | 14       | 2.0 (16.67%)                   | 6.0 (75.00%)                    |
| [Japanese encephalitis](./Japanese%20encephalitis)                                   | 12        | / (/)                          | / (/)                           | 2        | / (/)                          | / (/)                           |
| [Dengue](./Dengue)                                                                   | 1,685     | -3,703.0 (-68.73%)             | 1,511.0 (868.39%)               | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Anthrax](./Anthrax)                                                                 | 36        | -11.0 (-23.40%)                | 13.0 (56.52%)                   | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Dysentery](./Dysentery)                                                             | 1,963     | / (/)                          | / (/)                           | 1        | / (/)                          | / (/)                           |
| [Tuberculosis](./Tuberculosis)                                                       | 57,432    | -1,807.0 (-3.05%)              | 9,080.0 (18.78%)                | 320      | -34.0 (-9.60%)                 | -13.0 (-3.90%)                  |
| [Typhoid fever and paratyphoid fever](./Typhoid%20fever%20and%20paratyphoid%20fever) | 377       | -103.0 (-21.46%)               | -42.0 (-10.02%)                 | 0        | -1.0 (-100.00%)                | 0.0 (/)                         |
| [Meningococcal meningitis](./Meningococcal%20meningitis)                             | 12        | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Pertussis](./Pertussis)                                                             | 6,410     | 1,980.0 (44.70%)               | 4,250.0 (196.76%)               | 2        | 2.0 (/)                        | 2.0 (/)                         |
| [Diphtheria](./Diphtheria)                                                           | 0         | 0.0 (/)                        | 0.0 (/)                         | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Neonatal tetanus](./Neonatal%20tetanus)                                             | 1         | -1.0 (-50.00%)                 | 0.0 (0.00%)                     | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Scarlet fever](./Scarlet%20fever)                                                   | 4,637     | 2,104.0 (83.06%)               | 2,741.0 (144.57%)               | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Brucellosis](./Brucellosis)                                                         | 4,540     | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Gonorrhea](./Gonorrhea)                                                             | 10,065    | -263.0 (-2.55%)                | 2,435.0 (31.91%)                | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Syphilis](./Syphilis)                                                               | 57,719    | 738.0 (1.30%)                  | 22,567.0 (64.20%)               | 1        | -2.0 (-66.67%)                 | -2.0 (-66.67%)                  |
| [Leptospirosis](./Leptospirosis)                                                     | 25        | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Schistosomiasis](./Schistosomiasis)                                                 | 3         | 1.0 (50.00%)                   | -5.0 (-62.50%)                  | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Malaria](./Malaria)                                                                 | 183       | -10.0 (-5.18%)                 | 109.0 (147.30%)                 | 0        | -1.0 (-100.00%)                | 0.0 (/)                         |
| [Human infection with H7N9 virus](./Human%20infection%20with%20H7N9%20virus)         | 0         | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Monkey pox](./Monkey%20pox)                                                         | 80        | -47.0 (-37.01%)                | / (/)                           | 0        | 0.0 (/)                        | / (/)                           |
| [Influenza](./Influenza)                                                             | 1,862,998 | 1,522,029.0 (446.38%)          | 1,780,335.0 (2153.73%)          | 1        | 0.0 (0.00%)                    | 1.0 (/)                         |
| [Mumps](./Mumps)                                                                     | 7,642     | -645.0 (-7.78%)                | -1,060.0 (-12.18%)              | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Rubella](./Rubella)                                                                 | 89        | -21.0 (-19.09%)                | -31.0 (-25.83%)                 | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Acute hemorrhagic conjunctivitis](./Acute%20hemorrhagic%20conjunctivitis)           | 4,940     | -18,171.0 (-78.62%)            | 3,202.0 (184.23%)               | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Leprosy](./Leprosy)                                                                 | 34        | 10.0 (41.67%)                  | 14.0 (70.00%)                   | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Typhus](./Typhus)                                                                   | 170       | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Kala azar](./Kala%20azar)                                                           | 19        | 0.0 (0.00%)                    | 8.0 (72.73%)                    | 0        | -1.0 (-100.00%)                | 0.0 (/)                         |
| [Echinococcosis](./Echinococcosis)                                                   | 387       | 76.0 (24.44%)                  | 290.0 (298.97%)                 | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Filariasis](./Filariasis)                                                           | 0         | 0.0 (/)                        | 0.0 (/)                         | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Infectious diarrhea](./Infectious%20diarrhea)                                       | 73,835    | / (/)                          | / (/)                           | 0        | / (/)                          | / (/)                           |
| [Hand foot and mouth disease](./Hand%20foot%20and%20mouth%20disease)                 | 92,955    | -72,572.0 (-43.84%)            | 42,322.0 (83.59%)               | 0        | 0.0 (/)                        | 0.0 (/)                         |
| [Total](./Total)                                                                     | 2,352,301 | 1,417,130.0 (151.54%)          | 1,884,328.0 (402.66%)           | 2,626    | 125.0 (5.00%)                  | 756.0 (40.43%)                  |


# Cite Us

If you use CNIDS in your research, please cite the following paper:

```

```
